目次

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Digital BiomarkersMarket Summary, 2021

Chapter 3 Digital Biomarkers Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Digital Biomarkers Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increased Popularity of Recent Innovations and Remote Technologies
3.3.1.2 Rising Usage of Smartphones and The Emergence of New Wearables
3.3.1.3 Expanding Therapeutic Area Application
3.3.1.4 Increasing Investment in Decentralized Clinical Trials
3.3.2 Market Restraints Analysis
3.3.2.1 Concerns about Data Privacy
3.3.2.1 Lack of Awareness and Poor Skilled Professionals in Emerging Economics
3.4 Digital Biomarkers Market Analysis Tools: Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Threat Of Substitutes
3.4.4 Threat Of New Entrants
3.4.5 Competitive Rivalry
3.5 Pestel Analysis
3.5.1 Political & Legal Landscape
3.5.2 Social Landscape
3.5.3 Technology Landscape
3.5.4 Environmental Analysis
3.6 Regulatory Framework
3.7 Technology Overview
3.8 Pricing Analysis
3.9 Covid-19 Impact Analysis
3.9.1 Current And Future Impact Analysis
3.9.2 Impact Of Covid-19 On Market Players

Chapter 4 Competitive Landscape
4.1 Market participation categorization
4.2 Public Companies
4.2.1 Company Market Position Analysis
4.2.2 Synergy Analysis: Major Deals & Strategic Alliances
4.3 Detailed list of market players

Chapter 5 Digital Biomarkers Market: Segment Analysis, by type, 2017 - 2030 (USD Million)
5.1 Type Movement Analysis, 2021 & 2030
5.1.1 Wearable
5.1.1.1 Wearable Market Estimates and Forecasts, 2017 - 2030 (Million)
5.1.2 Mobile Based Applications
5.1.2.1 Mobile Based Applications Market Estimates and Forecasts, 2017 - 2030 (Million)
5.1.3 Sensors
5.1.3.1 Sensors Market Estimates and Forecasts, 2017 - 2030 (Million)
5.1.4 Others
5.1.4.1 Others Market Estimates and Forecasts, 2017 - 2030 (Million)

Chapter 6 Digital Biomarkers Market: Segment Analysis, by Clinical Practice, 2017 - 2030 (USD Million)
6.1 Clinical Practice Movement Analysis, 2021 & 2030
6.1.1 Diagnostic Digital Biomarkers
6.1.1.1 Diagnostic Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
6.1.2 Monitoring Digital Biomarkers
6.1.2.1 Monitoring Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
6.1.3 Predictive and Prognostic Digital Biomarkers
6.1.3.1 Predictive and Prognostic Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
6.1.4 Others
6.1.4.1 Others Market Estimates and Forecasts, 2017 - 2030 (Million)

Chapter 7 Digital Biomarkers Market: Segment Analysis, by Therapeutic Area, 2017 - 2030 (USD Million)
7.1 Therapeutic Area Movement Analysis, 2021 & 2030
7.1.1 Cardiovascular and Metabolic Disorders (CVMD)
7.1.1.1 Cardiovascular and Metabolic Disorders (CVMD) Market Estimates and Forecasts, 2017 - 2030 (Million)
7.1.2 Respiratory Disorders
7.1.2.1 Respiratory Disorders Market Estimates and Forecasts, 2017 - 2030 (Million)
7.1.3 Psychiatric Disorders
7.1.3.1 Psychiatric Disorders Market Estimates and Forecasts, 2017 - 2030 (Million)
7.1.4 Sleep & Movement Disease
7.1.4.1 Sleep & Movement Disease Market Estimates and Forecasts, 2017 - 2030 (Million)
7.1.5 Neurological Disorders
7.1.5.1 Neurological Disorders Market Estimates and Forecasts, 2017 - 2030 (Million)
7.1.6 Musculoskeletal Disorders
7.1.6.1 Musculoskeletal Disorders Market Estimates and Forecasts, 2017 - 2030 (Million)
7.1.7 Others
7.1.7.1 Others Market Estimates and Forecasts, 2017 - 2030 (Million)

Chapter 8 Digital Biomarkers Market: Segment Analysis, by End-Use, 2017 - 2030 (USD Million)
8.1 End-Use Movement Analysis, 2021 & 2030
8.1.1 Healthcare Companies
8.1.1.1 Healthcare Companies Market Estimates and Forecasts, 2017 - 2030 (Million)
8.1.2 Healthcare Providers
8.1.2.1 Healthcare ProvidersMarket Estimates and Forecasts, 2017 - 2030 (Million)
8.1.3 Payers
8.1.3.1 Payers Market Estimates and Forecasts, 2017 - 2030 (Million)
8.1.4 Others
8.1.4.1 Others Market Estimates and Forecasts, 2017 - 2030 (Million)

Chapter 9 Digital Biomarkers Market: Regional Market Analysis, by type, clinical practice, therapeutic area, and end-Use, 2017 - 2030 (USD Million)
9.1 Market Size, & Forecasts, Volume, and Trend Analysis, 2017 to 2030
9.2 North America
9.2.1 North America Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.2.2 U.S.
9.2.2.1 U.S. Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.2.3 Canada
9.2.3.1 Canada Digital Biomarkers Market Estimates and Forecasts, 2017 -2030 (Million)
9.3 Europe
9.3.1 Europe Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.3.2 U.K.
9.3.2.1 U.K. Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.3.3 Germany
9.3.3.1 Germany Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.3.4 Netherlands
9.3.4.1 Netherlands Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.3.5 Italy
9.3.5.1 Italy Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.3.6 Switzerland
9.3.6.1 Switzerland Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.4.2 Japan
9.4.2.1 Japan Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.4.3 China
9.4.3.1 China Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.4.4 Australia
9.4.4.1 Australia Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.4.5 India
9.4.5.1 India Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.4.6 South Korea
9.4.6.1 South Korea Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.5 Latin America
9.5.1 Latin America Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.5.2 Brazil
9.5.2.1 Brazil Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.5.3 Mexico
9.5.3.1 Mexico Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.6 MEA
9.6.1 MEA Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.6.2 South Africa
9.6.2.1 South Africa Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)
9.6.3 Israel
9.6.3.1 Israel Digital Biomarkers Market Estimates and Forecasts, 2017 - 2030 (Million)

Chapter 10 Company Profiles
10.1 ActiGraph LLC
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Product Benchmarking
10.1.4 Strategic Initiatives
10.2 AliveCor Inc
10.2.1 Company Overview
10.2.2 Financial Performance
10.2.3 Product Benchmarking
10.2.4 Strategic Initiatives
10.3 Koneksa
10.3.1 Company Overview
10.3.2 Financial Performance
10.3.3 Product Benchmarking
10.3.4 Strategic Initiatives
10.4 Amgen Inc.
10.4.1 Company Overview
10.4.2 Financial Performance
10.4.3 Product Benchmarking
10.4.4 Strategic Initiatives
10.5 Biogen Inc.
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiatives
10.6 Altoida Inc
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Product Benchmarking
10.6.4 Strategic Initiatives
10.7 IXICO plc
10.7.1 Company Overview
10.7.2 Financial Performance
10.7.3 Product Benchmarking
10.7.4 Strategic Initiatives
10.8 Adherium Limited
10.8.1 Company Overview
10.8.2 Financial Performance
10.8.3 Product Benchmarking
10.8.4 Strategic Initiatives
10.9 Empatica Inc
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Product Benchmarking
10.9.4 Strategic Initiatives
10.10 Huma
10.10.1 Company Overview
10.10.2 Financial Performance
10.10.3 Product Benchmarking
10.10.4 Strategic Initiatives
10.11 VivoSense
10.11.1 Company Overview
10.11.2 Financial Performance
10.11.3 Product Benchmarking
10.11.4 Strategic Initiatives
10.12 ResApp (Pfizer)
10.12.1 Company Overview
10.12.2 Financial Performance
10.12.3 Product Benchmarking
10.12.4 Strategic Initiatives

List of Tables
Table 1. List of secondary sources
Table 2. List of key companies
Table 3. North America Digital Biomarkers market, by country, 2017 - 2030 (USD Million)
Table 4. North America Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 5. North America Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 6. North America Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 7. North America Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 8. U.S. Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 9. U.S. Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 10. U.S. Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 11. U.S. Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 12. Canada Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 13. Canada Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 14. Canada Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 15. Canada Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 16. Europe Digital Biomarkers market, by country, 2017 - 2030 (USD Million)
Table 17. Europe Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 18. Europe Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 19. Europe Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 20. Europe Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 21. U.K. Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 22. U.K. Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 23. U.K. Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 24. U.K. Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 25. Germany Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 26. Germany Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 27. Germany Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 28. Germany Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 29. Netherlands Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 30. Netherlands Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 31. Netherlands Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 32. Netherlands Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 33. Italy Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 34. Italy Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 35. Italy Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 36. Italy Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 37. Switzerland Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 38. Switzerland Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 39. Switzerland Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 40. Switzerland Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 41. Asia Pacific Digital Biomarkers market, by country, 2017 - 2030 (USD Million)
Table 42. Asia Pacific Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 43. Asia Pacific Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 44. Asia Pacific Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 45. Asia Pacific Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 46. China Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 47. China Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 48. China Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 49. China Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 50. Japan Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 51. Japan Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 52. Japan Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 53. Japan Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 54. India Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 55. India Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 56. India Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 57. India Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 58. Australia Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 59. Australia Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 60. Australia Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 61. Australia Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 62. South Korea Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 63. South Korea Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 64. South Korea Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 65. South Korea Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 66. LATAM Digital Biomarkers market, by country, 2017 - 2030 (USD Million)
Table 67. LATAM Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 68. LATAM Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 69. LATAM Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 70. LATAM Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 71. Brazil Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 72. Brazil Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 73. Brazil Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 74. Brazil Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 75. Mexico Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 76. Mexico Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 77. Mexico Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 78. Mexico Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 79. MEA Digital Biomarkers market, by country, 2017 - 2030 (USD Million)
Table 80. MEA Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 81. MEA Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 82. MEA Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 83. MEA Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 84. South Africa Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 85. South Africa Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 86. South Africa Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 87. South Africa Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 88. Israel Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 89. Israel Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 90. Israel Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 91. Israel Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)
Table 92. Global Digital Biomarkers market, by region, 2017 - 2030 (USD Million)
Table 93. Global Digital Biomarkers market, by type, 2017 - 2030 (USD Million)
Table 94. Global Digital Biomarkers market, by clinical practice, 2017 - 2030 (USD Million)
Table 95. Global Digital Biomarkers market, by therapeutic area, 2017 - 2030 (USD Million)
Table 96. Global Digital Biomarkers market, by end-use, 2017 - 2030 (USD Million)

List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD Modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Segment-Based Penetration Model
Fig. 11 Market summary (2021, Million)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Market variable analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Digital Biomarkers Market: By Type Movement Analysis, 2021 & 2030
Fig. 17 Wearable Market, 2017 - 2030 (Million)
Fig. 18 Mobile based Applications Market, 2017 - 2030 (Million)
Fig. 19 Sensors Market, 2017 - 2030 (Million)
Fig. 20 Others Market, 2017 - 2030 (Million)
Fig. 21 Digital Biomarkers Market: By Clinical Practice Movement Analysis, 2021 & 2030
Fig. 22 Diagnostic digital biomarkers market, 2017 - 2030 (Million)
Fig. 23 Monitoring digital biomarkers market, 2017 - 2030 (Million)
Fig. 24 Predictive and Prognostic digital biomarkers market, 2017 - 2030 (Million)
Fig. 25 Others digital biomarker market, 2017 - 2030 (Million)
Fig. 26 Digital Biomarkers Market: By Therapeutic Area Movement Analysis, 2021 & 2030
Fig. 27 Cardiovascular and metabolic disorders (CVMD) market, 2017 - 2030 (Million)
Fig. 28 Respiratory disorders market, 2017 - 2030 (Million)
Fig. 29 Psychiatric disorders market, 2017 - 2030 (Million)
Fig. 30 Sleep & movement disease market, 2017 - 2030 (Million)
Fig. 31 Neurological disorders market, 2017 - 2030 (Million)
Fig. 32 Musculoskeletal disorders market, 2017 - 2030 (Million)
Fig. 33 Others market, 2017 - 2030 (Million)
Fig. 34 Digital Biomarkers Market: By End-Use Movement Analysis, 2021 & 2030
Fig. 35 Healthcare companies market, 2017 - 2030 (Million)
Fig. 36 Healthcare Providers market, 2017 - 2030 (Million)
Fig. 37 Payers market, 2017 - 2030 (Million)
Fig. 38 Others market, 2017 - 2030 (Million)
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 Regional outlook, 2021 & 2030
Fig. 41 North America Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 42 U.S. Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 43 Canada Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 44 Europe Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 45 U.K. Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 46 Germany Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 47 Netherlands Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 48 Italy Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 49 Switzerland Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 50 Asia Pacific Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 51 Japan Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 52 China Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 53 India Digital Biomarkers Market, 2017- 2030 (Million)
Fig. 54 South Korea Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 55 Australia Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 56 Latin America Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 57 Brazil Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 58 Mexico Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 59 MEA Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 60 South Africa Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 61 Israel Digital Biomarkers Market, 2017 - 2030 (Million)
Fig. 62 Market Participation Categorization
Fig. 63 Company market position analysis